What Makes a Dental Practice Business Worth More?

DSO buyers are paying 6–8x EBITDA for individual dental practices in 2026, and platform acquisitions with regional clusters of offices can command 9–11x. A single-doctor practice generating $500K in EBITDA can realistically expect an offer in the $3M–$4M range from an active DSO buyer — and higher if there is room to add an associate or expand hygiene production. The practices that command top-of-range multiples share three consistent traits: strong hygiene production, low doctor dependency, and a diversified payor mix.

What hygiene and production metrics matter most to DSO buyers?

DSO buyers evaluate dental practices on production metrics that go well beyond topline revenue. Hygiene production as a percentage of total practice revenue is a primary metric — buyers want to see hygiene comprising 25–35% of total production, with a recall adherence rate above 60%. Low hygiene production signals doctor dependence: if revenue stops when the doctor stops producing, the practice carries transition risk that buyers price in.

New patient flow matters too — DSOs want to see 15–25+ new patients per month, demonstrating marketing effectiveness and community reputation. Collections rate (ideally 98%+) and accounts receivable aging (minimal 90+ day balances) signal clean billing operations. Case acceptance rate, average transaction value, and the ratio of hygienists to doctors all factor into EBITDA quality assessments. A practice that scores well across these metrics can command a premium multiple even at lower total revenue — because the buyer sees predictable, recurring earnings rather than snapshot revenue. Practices with EBITDA margins above 25% consistently command higher multiples regardless of size.

How does payor mix and specialty affect dental practice value?

Payor mix is one of the most scrutinized elements of a dental practice valuation. DSO buyers prefer a diversified mix of PPO, fee-for-service, and in-network commercial insurance — practices that are heavily Medicaid-dependent (over 40–50% of revenue) typically see compressed multiples because of reimbursement rate risk and billing complexity. Cash-pay and fee-for-service patients carry higher transaction values and signal a premium patient demographic. Active DSO buyers in 2026 include Heartland Dental, Aspen Dental, MB2 Dental, Pacific Dental Services, and Smile Brands. Each has specific acquisition criteria around geography, specialty mix, and minimum EBITDA — which is why working with a broker who actively markets to multiple buyer groups matters.

Specialty capability adds value: practices with in-house implants, Invisalign, or oral surgery can bill higher-value procedures. However, specialty production that depends entirely on the selling doctor presents continuity risk — buyers want to see that specialty revenue can be maintained or replaced post-transition. Multi-doctor practices with an associate in place are the cleanest acquisition targets because the buyer isn't entirely dependent on a single clinician. If you're not talking to at least three or four different buyer groups, you're almost certainly leaving money on the table.

"Dental practices are one of the most competitive M&A markets I work in right now. DSO buyers are disciplined — they know exactly what they want and they pay well for it. What surprises most selling dentists is how much hygiene production matters. They're not just buying your chair count; they're buying recurring preventive care revenue and the patient relationships that come with it. A practice with three hygienists and a recall rate above 65% gets valued very differently than one that's been deferring hygiene scheduling. I tell every dentist I work with: the year before you sell, optimize hygiene first. It's the fastest way to move the needle on your multiple." — John M. Salony